Life Course Immunisation - Cost-effectiveness of immunisation at the global level.

Reducing healthcare costs costs in the short term by down the line by reducing the reducing the incidence or severity of secondary conditions. [...] Reducing healthcare costs in the short term The cost of each adult This generated an Spanish healthcare hospitalisation due to approximate total systems spent €134.1 serious pneumococcal cost of £731 million million in 2015 on disease was calculated ($911 million) treating four vaccine- to be £3,904 ($4,868) in to England’s health preventable diseases England in 2019 system in 2019 in people aged. [...] Reducing long-term costs of healthcare for secondary conditions • People who’ve had flu or pneumonia may be six times more likely to suffer from a heart attack or stroke in the days after infection [Warren-Gash et al, 2018] • Since reports of measles reached near zero in the US in 2000, incidents of subacute sclerosing panencephalitis (SSPE, a brain disorder) are very rarely reported in the region. [...] • People who report being in good rather than poor health are over four times more likely to be in work between the ages of 50 and 65, and over 10 times more likely between 65 and 74. [...] And it’s the right thing to do What next? • We will engage G20 health ministers on life course immunisation at an ILC-UK event in Gandhinagar, India in August 2023 • We will undertake original analysis to further understand the opportunities for cost-effective life course immunisation programmes in an ageing world • We will use our original analysis produce actionable and positive steps that healt.